3 Quality Dividend Aristocrats to Buy in June

Income investors heading into the backmost fractional of 2026 look a acquainted tension: stretched broad-market multiples versus a shrinking excavation of stocks that really turn their dividends done cycles. The classical Dividend Aristocrat screen, 25-plus years of consecutive increases, surfaces the close benignant of name. We brace 2 bona fide Aristocrats with 1 reliable dividend grower that does not yet qualify, but funds its payout from infrastructure currency flows the mode an Aristocrat would.

Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) is the cleanest look of the Aristocrat thesis. The committee approved its 64th consecutive yearly dividend summation successful April, taking the quarterly payout to $1.34 per share, a 3% rise from $1.30, with an ex-date of May 26, 2026 and outgo connected June 9, 2026.

The fundamentals backmost the streak. Q1 2026 gross came successful astatine $24.06 billion, up 10% twelvemonth implicit year, and adjusted EPS of $2.70 bushed the $2.6773 consensus, marking 4 consecutive EPS beats. Management raised full-year 2026 guidance to $100.3B–$101.3B successful gross and $11.45–$11.65 successful adjusted EPS. Oncology is the engine: DARZALEX deed $3.96 cardinal (+23%), CARVYKTI $597 cardinal (+62%), and TREMFYA $1.61 cardinal (+68%), offsetting STELARA's biosimilar erosion.

Shares astatine $241.90 commercialized astatine a guardant P/E of 20 against an expert people of $252.87. The output sits astatine astir 2%, little than the humanities mean aft a 17% YTD run.

Risk: STELARA fell 60% twelvemonth implicit twelvemonth to $656 million, and the institution absorbed a $330 cardinal litigation complaint successful Q1. The planned Orthopaedics separation wrong 18–24 months adds execution risk.

Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Johnson & Johnson didn't marque the cut. Grab the names FREE today.

McDonald's (NYSE:MCD)

McDonald's (NYSE:MCD) is the contrarian Aristocrat. Shares are down 10% twelvemonth to day and disconnected 6% implicit the past week, precisely erstwhile high-quality compounders merit a 2nd look.

The dividend backdrop is rare. Management's 5% rise declared successful October 2025 took the quarterly payout to $1.86 per share, with the astir caller outgo connected June 16, 2026. Q1 2026 results bushed connected some lines: gross of $6.52 billion, up 9%, and EPS of $2.83 versus $2.7446 consensus. Global comparable income roseate 4%, against -1% the anterior year, with U.S. comps astatine +4%.